Evidence map›Paper›PMID 32758301›Full record

ReviewInternational braz j urol : official journal of the Brazilian Society of Urology

Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?

Marcio Augusto Averbeck, Jorge Moreno-Palacios, Alejandro Aparicio

Open access · diamondAbstract readReview
In one paragraph

Review in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2021
    Article
  14. Perspectives on urological care in multiple sclerosis patients.Intractable & rare diseases research · 2021
    Review
  15. Article
  16. Article
  17. Neurogenic bladder - concepts and treatment recommendations.International braz j urol : official journal of the Brazilian Society of Urology
    Review
  18. Intravaginal eletrical stimulation for bladder training method.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Marcio Augusto AverbeckCoordenador de Neurourologia, Unidade de Videourodinâmica, Moinhos de Vento Hospital, Porto Alegre, RS, Brasil.
Jorge Moreno-PalaciosServicio de Urologia, Unidad de Alta Especialidad Centro Médico Nacional Siglo XXI, IMSS, México, MX.
Alejandro AparicioClinica del Country, Bogota, Colombia.
Clínica Santa María · COHospital Moinhos de Vento · BRMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review current literature regarding sacral neuromodulation (SNM) for neurogenic lower urinary tract dysfunction (NLUTD) focused on indications, barriers and latest technological developments. MATERIAL AND

methodsA PubMed database search was performed in April 2020, focusing on SNM and various neuro-urological conditions.

resultsSNM has been increasingly indicated for lower urinary tract dysfunction (LUTD) in neuro-urological patients. Most studies are cases series with several methodological limitations and limited follow-up, lacking standardized definition for SNM clinical success. Most series focused on neurogenic overactive bladder in spinal cord injured (incomplete lesions) and multiple sclerosis patients. Barriers for applying this therapy in neurogenic LUTD were mainly related to magnetic resonance imaging incompatibility, size of the implantable pulse generator (IPG), and battery depletion. Newer technological advances have been made to address these limitations and will be widely available in the near future.

conclusionsSNM seems a promising therapy for neurogenic LUTD in carefully selected patients with incomplete lesions. Further studies are still needed to define which subgroups of neurological patients benefit the most from this minimally invasive technique.

Indexed as

Electric Stimulation TherapyUrinary Bladder, NeurogenicHumansSacrumlower urinary tract symptomsneurogenic bladderSacral neuromodulation

Identifiers

PMID32758301
PMCPMC7527110
OpenAlexW3048361156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.